[
  {
    "ts": null,
    "headline": "Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year",
    "summary": "Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.",
    "url": "https://finnhub.io/api/news?id=4998f171812e5ea27283b49d00a53b73a73447f2e8d5d86ba3152ea8d7ef0677",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737465900,
      "headline": "Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year",
      "id": 132437459,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1795495467/image_1795495467.jpg?io=getty-c-w1536",
      "related": "MGM",
      "source": "SeekingAlpha",
      "summary": "Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.",
      "url": "https://finnhub.io/api/news?id=4998f171812e5ea27283b49d00a53b73a73447f2e8d5d86ba3152ea8d7ef0677"
    }
  },
  {
    "ts": null,
    "headline": "Longleaf Partners Fund 2024 Annual Commentary",
    "summary": "The Longleaf Partners Fund returned -1.33% in the fourth quarter, compared to the S&P 500âs return of 2.41% and the Russell 1000 Valueâs return of -1.98%. Read more here.",
    "url": "https://finnhub.io/api/news?id=702c68b2da0171c010232fe4dc6b8b62b30cdd27b7d1b3728a33f1ee91c5accd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737451380,
      "headline": "Longleaf Partners Fund 2024 Annual Commentary",
      "id": 132436328,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1688767071/image_1688767071.jpg?io=getty-c-w1536",
      "related": "MGM",
      "source": "SeekingAlpha",
      "summary": "The Longleaf Partners Fund returned -1.33% in the fourth quarter, compared to the S&P 500âs return of 2.41% and the Russell 1000 Valueâs return of -1.98%. Read more here.",
      "url": "https://finnhub.io/api/news?id=702c68b2da0171c010232fe4dc6b8b62b30cdd27b7d1b3728a33f1ee91c5accd"
    }
  },
  {
    "ts": null,
    "headline": "Artisan Mid Cap Value Fund Q4 2024 Commentary",
    "summary": "Our portfolio generated a strong absolute return but trailed the Russell MidcapÂ® Value Index. Read more here.",
    "url": "https://finnhub.io/api/news?id=9ec7250c1a09ede2a7fd410807b5ae5844c8b53addb105a959e370ff207bb3a0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737447600,
      "headline": "Artisan Mid Cap Value Fund Q4 2024 Commentary",
      "id": 132435986,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158808037/image_2158808037.jpg?io=getty-c-w1536",
      "related": "MGM",
      "source": "SeekingAlpha",
      "summary": "Our portfolio generated a strong absolute return but trailed the Russell MidcapÂ® Value Index. Read more here.",
      "url": "https://finnhub.io/api/news?id=9ec7250c1a09ede2a7fd410807b5ae5844c8b53addb105a959e370ff207bb3a0"
    }
  }
]